drugset / Trial / NCT02902653

Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction

NCT02902653

Phase 4 Unknown 372 enrolled Oihane Lapuente Ocamica
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the efficacy and safety of the administration of oral misoprostol versus vaginal dinoprostone and vaginal misoprostol for cervical ripening and labor induction.

Timeline

Start
2016-09
Primary completion
2020-09
Completion
2020-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dinoprostone Other / unclassified 10 mg Intravenous
Comparator Misoprostol Other / unclassified 25 ug Intravenous
Comparator Misoprostol Other / unclassified Oral

Indications

No indication recorded.